Effect of Albumin on Underpotential Lead Deposition and Stripping on Ag-RDE

Investigation of hexacyanoferrate(II)/(III) charge-dependent interactions with bovine and human serum albumins

In the present paper, the binding interactions of highly negative-charged ions, namely hexacyanoferrates(II/III), i.e. [Fe(CN)₆]^4- and [Fe(CN)₆]^3- with bovine and human serum albumins (BSA and HSA, respectively) have been studied for the first time in an aqueous solution (10 mM cacodylate buffer of pH 7.0) using steady-state fluorescence spectroscopy, isothermal titration calorimetry, and CD spectroscopy supported by molecular dynamics-based computational approaches. The Stern-Volmer equation as well as its modifications suggested that hexacyanoferrates(II/III) effectively quenched the intrinsic fluorescence of the albumins through a static mechanism. The proteins under study possess only one binding site on the surface capable of binding one mole of hexacyanoferrates(II/III) ions per one mole of albumin (HSA or BSA). The formation of albumin complexes is an enthalpy-driven process (|ΔH_ITC| > |TΔS_ITC|). The strength of the interactions depends mainly on the type of albumin, and changes as follows: BSA-K₃[Fe(CN)₆] ∼ BSA-K₄[Fe(CN)₆] > HSA-K₃[Fe(CN)₆] ∼ HSA-K₄[Fe(CN)₆]. Finally, potential binding sites of bovine and human serum albumins have been investigated and discussed based on a competitive fluorescence displacement assay (with warfarin and ibuprofen as site markers) and molecular dynamics simulations.

Interactions of adsorbed albumin with underpotentially deposited copper on gold piezoelectrodes

The adsorption of a model protein, bovine serum albumin (BSA), on Au electrodes was investigated using the Cu adatom probe method and Electrochemical Quartz Crystal Nanobalance (EQCN) technique. The adsorption of BSA was confirmed by AFM imaging and has been found to be controlled by kinetics. Using the Cu adatom probe method, we were able to reconstruct the entire BSA adsorption transient Theta(BSA) vs. t. The adsorption rate constant k(1), determined from this transient is k(1)=2.45x10(5) L mol(-1) s(-1). We have found that the bulk Cu(0) deposition process is blocked by BSA adsorption and it decays exponentially with time during BSA adsorption. It ceases completely when a full monolayer of BSA is formed. In contrast to that, the mass associated with Cu-u.p.d. decreases only to ca. 50% of that in the absence of BSA, indicating that Cu adatoms can penetrate (wedge) into the space between the surface Au atoms and the adsorbed BSA molecules. In addition to that, we have found that the degree of penetration of Cu adatoms can be controlled by the applied deposition potential. By selecting a sufficiently cathodic potential, we were able to deposit a full Cu-u.p.d. monolayer, independent of the BSA surface coverage extending from Theta(BSA)=0 to Theta(BSA) approximately 1. The positive shift of Cu(ad) desorption peak potential E(p), observed in the presence of adsorbed BSA, has been interpreted in terms of Frumkin exchange interaction forces between Cu(ad) and BSA(ad), on the basis of our earlier theoretical model, expanded here to include adsorbed species in two monolayers. This expansion is possible owing to the fast rate of Cu adatom penetration in the interfacial region. From the plots of E(p) vs. Theta(BSA), the presence of strong attractive interactions between Cu(ad) and BSA(ad) was deduced. These interactions result in a super-shift of the Cu-u.p.d. desorption peak potential, corresponding to the exchange interaction coefficient g(M,X)<-4, indicating on a possibility of the formation of a stable interface complex.

Spectrofluorimetric studies on the binding of salicylic acid to bovine serum albumin using warfarin and ibuprofen as site markers with the aid of parallel factor analysis

The interactions of salicylic acid (SL) and two different site markers (warfarin for site I and ibuprofen for site II) with bovine serum albumin (BSA) in pH 7.4 Tris-HCl buffer have been investigated with the use of spectrofluorimetry. An equilibrium solution of BSA and SA was titrated separately with the two markers. This initial work showed that the binding of SL with BSA could be quite complex, and that there was probably a competitive interaction occurring between ibuprofen and SL. However, the spectral results were difficult to interpret clearly for the interaction of warfarin and SL in similar circumstances. To extract more information from the resolution of fluorescence excitation-emission spectra, the contour plots of the fluorescence spectra indicated that the optimal excitation wavelengths for BSA, SL, warfarin and ibuprofen were different, and were found to be at 278, 295, 306 and 218 nm, respectively. The spectral information was arranged into three-way excitation-emission fluorescence matrix (EEM) stack arrays, and was submitted for analysis by the parallel factor analysis (PARAFAC) algorithm. Firstly, it was demonstrated that the estimated excitation and emission spectral responses for SL, BSA and the site markers, warfarin and ibuprofen, agreed well with the measured spectra. Then, the interpretation of the plots of simultaneously extracted (by PARAFAC) equilibrium concentrations for the above four reactants, showed that: (i) the SL primarily appears to bind in site I but at a different location from the high-affinity binding site (HAS) for warfarin, and the interaction partially overlaps with the low-affinity binding site (LAS) for warfarin. (ii) The SL may have two LAS-one in site II where the HAS for ibuprofen is located, and the other in site I at the LAS for ibuprofen. Thus, application of the PARAFAC method for the study of competitive interaction of SL and BSA with the aid of two different site markers has extracted information unobtainable by traditional methods such as the Scatchard plot, and provided useful means of data visualization.